有机硫化合物是指含有硫原子的有机化合物。这些化合物在自然界中广泛存在,在医药、农药和材料科学等领域有着重要的应用。有机硫化合物因其化学性质独特,在药物设计、合成化学以及材料制备方面扮演着重要角色。
1. 结构与分类有机硫化合物可以按硫的连接方式分为饱和和不饱和类,如二硫化物、噻吩衍生物、砜等。常见的结构类型有:
许多有机硫化合物在生物学上有重要功能或应用潜力。例如:
有机硫化合物可通过多种途径合成:
有机硫化合物的应用广泛:
尽管有机硫化合物具有许多潜在益处,但其生产和使用也可能对环境造成影响。因此,在设计和合成这些化合物时需要考虑可持续性和环保性因素。
以上是对有机硫化合物的简单介绍,包括它们的结构、生物学活性、合成方法及其应用领域等基本信息。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
—— | N-[(1R,3S)-1-cyano-3-methylcyclohexyl]-2-propylsulfonylacetamide | —— | C13H22N2O3S |
|
—— | N-[(1S,3R)-1-cyano-3-methylcyclohexyl]-2-propylsulfonylacetamide | —— | C13H22N2O3S |
|
—— | 2-cyclopentylsulfonyl-N-[(3S)-1-(dimethylamino)-4,4-dimethylpentan-3-yl]acetamide | —— | C16H32N2O3S |
|
—— | 2-cyclopentylsulfonyl-N-[(3R)-1-(dimethylamino)-4,4-dimethylpentan-3-yl]acetamide | —— | C16H32N2O3S |
|
—— | 5-[(4-chlorophenyl)sulfanylmethyl]-3-[(1R)-1-ethoxyethyl]-1,2,4-oxadiazole | —— | C13H15ClN2O2S |
|
—— | 1-ethyl-3-(6-ethylsulfanylpyridin-3-yl)-1-[(1R)-1-pyridin-3-ylethyl]urea | —— | C17H22N4OS |
|
—— | 5-[(4-chlorophenyl)sulfanylmethyl]-3-[(1S)-1-ethoxyethyl]-1,2,4-oxadiazole | —— | C13H15ClN2O2S |
|
—— | ethyl (3S)-3-[4-(trifluoromethyl)pyrimidin-2-yl]sulfanylbutanoate | —— | C11H13F3N2O2S |
|
—— | ethyl (3R)-3-(5-bromopyrimidin-2-yl)sulfanylbutanoate | —— | C10H13BrN2O2S |
|
—— | 1-ethyl-3-(6-ethylsulfanylpyridin-3-yl)-1-[(1S)-1-pyridin-3-ylethyl]urea | —— | C17H22N4OS |
|
—— | ethyl (3S)-3-(5-bromopyrimidin-2-yl)sulfanylbutanoate | —— | C10H13BrN2O2S |
|
—— | ethyl (3R)-3-[4-(trifluoromethyl)pyrimidin-2-yl]sulfanylbutanoate | —— | C11H13F3N2O2S |
|
—— | 2-(2,4-difluorophenyl)sulfanyl-N-[(3R)-3-methyl-1,1-dioxothiolan-3-yl]acetamide | —— | C13H15F2NO3S2 |
|
—— | 2-(2,4-difluorophenyl)sulfanyl-N-[2-(4-methylphenyl)sulfanylethyl]acetamide | —— | C17H17F2NOS2 |
|
—— | 2-(2,4-difluorophenyl)sulfanyl-N-(2-phenylsulfanylethyl)acetamide | —— | C16H15F2NOS2 |
|
—— | N-[(3R,4R)-4-chloro-1,1-dioxothiolan-3-yl]-2-(2,4-difluorophenyl)sulfanylacetamide | —— | C12H12ClF2NO3S2 |
|
—— | 2-(2,5-difluorophenyl)sulfanyl-N-[(4-methylphenyl)methyl]acetamide | —— | C16H15F2NOS |
|
—— | N-[(1R)-1-(2-bromophenyl)ethyl]-2-(2,4-difluorophenyl)sulfanylacetamide | —— | C16H14BrF2NOS |
|
—— | 2-(2,4-difluorophenyl)sulfanyl-N-[2-[(2-fluorophenyl)methylsulfanyl]ethyl]acetamide | —— | C17H16F3NOS2 |
|
—— | N-[(1S)-1-(4-bromophenyl)ethyl]-2-(2,4-difluorophenyl)sulfanylacetamide | —— | C16H14BrF2NOS |
|
—— | N-[(3S,4R)-4-chloro-1,1-dioxothiolan-3-yl]-2-(2,4-difluorophenyl)sulfanylacetamide | —— | C12H12ClF2NO3S2 |
|
—— | 2-[(2,4-Difluorophenyl)sulfanylmethyl]-5-(2,5-dimethylfuran-3-yl)-1,3,4-oxadiazole | —— | C15H12F2N2O2S |
|
—— | N-(1-adamantylmethyl)-2-(2,4-difluorophenyl)sulfanylacetamide | —— | C19H23F2NOS |
|
—— | 2-(2,4-difluorophenyl)sulfanyl-N-[(1S)-1-(4-ethylphenyl)ethyl]acetamide | —— | C18H19F2NOS |
|
—— | 1-(4-acetyl-3,5-dimethyl-1H-pyrrol-2-yl)-2-(2,4-difluorophenyl)sulfanylethanone | —— | C16H15F2NO2S |
|
—— | N-[(2R)-2-cyano-3-methylbutan-2-yl]-2-(2,4-difluorophenyl)sulfanylacetamide | —— | C14H16F2N2OS |
|
—— | 2-(2,4-difluorophenyl)sulfanyl-N-[(1R,2R)-2-methylcyclohexyl]acetamide | —— | C15H19F2NOS |
|
—— | (2R)-2-(2,4-difluorophenyl)sulfanyl-N-[(1S,2S)-2-methylcyclohexyl]propanamide | —— | C16H21F2NOS |
|
—— | (2S)-N-(1-adamantyl)-2-(2,4-difluorophenyl)sulfanylpropanamide | —— | C19H23F2NOS |
|
—— | 2-(2,4-difluorophenyl)sulfanyl-N-[(1R)-1-(4-ethylphenyl)ethyl]acetamide | —— | C18H19F2NOS |
|
—— | N-(1-cyanocyclohexyl)-2-(2,4-difluorophenyl)sulfanyl-N-methylacetamide | —— | C16H18F2N2OS |
|
—— | 2-(2,4-difluorophenyl)sulfanyl-N-[2-(4-fluorophenyl)ethyl]acetamide | —— | C16H14F3NOS |
|
—— | (2R)-2-(2,4-difluorophenyl)sulfanylpropanamide | —— | C9H9F2NOS |
|
—— | N-[(2-chlorophenyl)methyl]-2-(2,4-difluorophenyl)sulfanylacetamide | —— | C15H12ClF2NOS |
|
—— | (2R)-2-(2,4-difluorophenyl)sulfanyl-N-[(1S,2R)-2-methylcyclohexyl]propanamide | —— | C16H21F2NOS |
|
—— | (2R)-N-cyclohexyl-2-(2,4-difluorophenyl)sulfanylpropanamide | —— | C15H19F2NOS |
|
—— | 2-(2,4-difluorophenyl)sulfanyl-N-(furan-2-ylmethyl)acetamide | —— | C13H11F2NO2S |
|
—— | N-[(4-chlorophenyl)methyl]-3-(3,4-difluorophenyl)sulfanylpropanamide | —— | C16H14ClF2NOS |
|
—— | (2S)-N-cyclohexyl-2-cyclopentylsulfonyl-N-methylpropanamide | —— | C15H27NO3S |
|
—— | (2R)-N-cyclohexyl-2-cyclopentylsulfonyl-N-methylpropanamide | —— | C15H27NO3S |
|
—— | 2-[(Z)-1-chloro-2-(4-methylsulfanylphenyl)ethenyl]-5-(2,5-dimethylfuran-3-yl)-1,3,4-oxadiazole | —— | C17H15ClN2O2S |
|
—— | 2-[3-[(Z)-2-tert-butyl-5,5-dimethyl-4-oxohex-2-enyl]sulfanyl-5-thiophen-2-yl-1,2,4-triazol-4-yl]acetamide | —— | C20H28N4O2S2 |
|
—— | (Z)-3-(5-bromothiophen-2-yl)-N-[2-(1-methylimidazol-2-yl)sulfanylphenyl]prop-2-enamide | —— | C17H14BrN3OS2 |
|
—— | 2-[[5-cyclohexyl-4-[(Z)-[4-(diethylamino)phenyl]methylideneamino]-1,2,4-triazol-3-yl]sulfanyl]acetic acid | —— | C21H29N5O2S |
|
—— | (Z)-3-pyridin-2-yl-N-(2-pyridin-2-ylsulfanylpyridin-4-yl)prop-2-enamide | —— | C18H14N4OS |
|
—— | (Z)-N-[4-(4,6-dimethylpyrimidin-2-yl)sulfanylphenyl]-3-(1-methylpyrazol-4-yl)prop-2-enamide | —— | C19H19N5OS |
|
—— | (Z)-N-[3-(4-cyclopentyl-5-methylsulfanyl-1,2,4-triazol-3-yl)propyl]-3-(1-methylpyrazol-4-yl)prop-2-enamide | —— | C18H26N6OS |
|
—— | N-[(1S)-1-(3,4-dimethylphenyl)ethyl]-2-(2-fluorophenyl)sulfanylacetamide | —— | C18H20FNOS |
|
—— | N-[6-amino-1-(2-methylpropyl)-2,4-dioxopyrimidin-5-yl]-N-butyl-2-(2-fluorophenyl)sulfanylacetamide | —— | C20H27FN4O3S |
|
—— | (E)-2-[[5-(4-fluorophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-3-(3-methylthiophen-2-yl)prop-2-enoate | —— | C16H10FN2O3S2- |
|